AHA: Cutting a Few Minutes of Sedentary Time Reduces Teens’ Risk for Insulin Resistance
via HealthDayTUESDAY, March 24, 2026 -- Shifting even a few minutes from being sedentary to either sleep or moderate-to-vigorous physical activity (MVPA) reduces insulin resistance in teens, according to a study presented at the American Heart Association Epidemiology and Prevention/Lifestyle and Cardiometabolic Health 2026 Scientific Sessions, held from March 17 to 20 in Boston.
Soren Harnois-Leblanc, Ph.D., R.D., from Harvard University in Boston, and colleagues used data from the ongoing Project Viva prebirth cohort (1999 to 2002) to analyze how the proportion of time spent in sleep, sedentary time, light physical activity (LPA), and MVPA in early adolescence was associated with glucose, insulin, and adiponectin in late adolescence. The analysis included 394 adolescents with both accelerometer and outcome data.
The researchers found on average in a 24-hour period, 33 percent of time was spent on sleep, 48 percent on sedentary activities, 17 percent on LPA, and 2 percent on MVPA. For those who allocated more time toward sleep or MVPA instead of sedentary time in early adolescence, lower Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) was seen in late adolescence (median age, 17.5 years). For example, reallocating 30 minutes of sedentary time to MVPA or to sleep was associated with a 14.8 percent or 4.7 percent reduction in HOMA-IR, respectively. No significant change in HOMA-IR was seen for reallocating to LPA. There were no significant associations for 24-hour activity composition and either adiponectin or fasting glucose.
"Our findings mean that switching from sedentary behaviors to moderate-to-vigorous physical activity or sleep, even if it is only a few minutes per day to start, was beneficial for health," Harnois-Leblanc said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-25 01:58
Read more
- For Teens, AI Dietary Recommendations Deviate From Dietitian Plans
- Reduction in Acetaminophen Orders in ED After White House Briefing
- PFOS, PFHA, Mono-Iso-Nonyl-Phthalate Can Predict Lung Cancer Mortality
- Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)
- Federal Judge Pauses Kennedy's Changes to Childhood Vaccine Schedule
- CDC Vaccine Advisory Panel To Revisit COVID Shot Safety Next Month
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions